abstract |
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1)-mediated diseases or disorders: n n n n n n n n n n wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are as defined herein. |